DigestRedComo funciona
Red
/
Empresas
No
No verificado

Novartis Pharma AG

Sobre qué escribimos

Anuncios brevesFarmacéuticaGestión empresarial/Administración de EmpresasMedicina Salud BienestarPublicidad/Marketing/Medios de comunicación/Comunicación

68 Comunicados de prensa

Ver todos los comunicados de prensa
24/11/2025
Farmacéutica
Anuncios breves
Novartis data underscore pioneering scientific innovation in Hematology and Oncology at ASH and SABCS
Fuente
Novartis Pharma AG
Editor
GLOBENEWSWIRE
1.00
0
24/11/2025
Farmacéutica
Medicina Salud Bienestar
Anuncios breves
Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)
Fuente
Novartis Pharma AG
Editor
GLOBENEWSWIRE
1.00
0
19/11/2025
Farmacéutica
Anuncios breves
Novartis projects +5-6% cc sales CAGR 2025-2030, with long-term growth backed by 30+ potential high-value pipeline assets
Fuente
Novartis Pharma AG
Editor
GLOBENEWSWIRE
1.00
0
19/11/2025
Farmacéutica
Anuncios breves
Novartis announces plans to build flagship manufacturing hub in North Carolina
Fuente
Novartis Pharma AG
Editor
GLOBENEWSWIRE
1.00
0
12/11/2025
Farmacéutica
Anuncios breves
Novartis Phase III trial for next-generation malaria treatment KLU156 (GanLum) meets primary endpoint, with potential to combat antimalarial resistance
Fuente
Novartis Pharma AG
Editor
GLOBENEWSWIRE
1.00
0
10/11/2025
Farmacéutica
Medicina Salud Bienestar
Anuncios breves
Novartis opens new radioligand therapy manufacturing facility in California as part of $23B US expansion plan
Fuente
Novartis Pharma AG
Editor
GLOBENEWSWIRE
1.00
0
03/11/2025
Farmacéutica
Anuncios breves
New Novartis data at ASN Kidney Week and AHA Scientific Sessions demonstrate momentum of broad CRM portfolio and pipeline
Fuente
Novartis Pharma AG
Editor
GLOBENEWSWIRE
1.00
0
29/10/2025
Farmacéutica
Anuncios breves
Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Phase III trials
Fuente
Novartis Pharma AG
Editor
GLOBENEWSWIRE
1.00
0
28/10/2025
Farmacéutica
Anuncios breves
Novartis completes acquisition of Tourmaline Bio
Fuente
Novartis Pharma AG
Editor
GLOBENEWSWIRE
1.00
0
27/10/2025
Farmacéutica
Anuncios breves
Novartis announces expiration of Tourmaline Bio tender offer 
Fuente
Novartis Pharma AG
Editor
GLOBENEWSWIRE
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0